BECOME MEMBER SUPPORT
Year Cancer type Speaker
Hall A Main Conference - ROS - 23 July 2022
Interpretation Of ROS 1 Rearrangement In NSCLC
Selection Of 1st Line Therapy For ROS 1 Rearrangement IN NSCLC
Mechanism Of Resistance To ROS 1and Therapy Post Resistance In NSCLC